Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TPMT | P51580 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5142273 | 0.71 | ALDH1A1 (0.40) | KDM4EALDH1A1HSD17B10TPMT | |
| SCHEMBL7523176 | 0.70 | PTPN1 (0.46) | KDM4EALDH1A1 | |
| SCHEMBL5682572 | 0.70 | LMNA (0.56) | KDM4ELMNA | |
| SCHEMBL28367230 | 0.69 | CA12 (0.35) | KDM4EALDH1A1HSD17B10LMNA | |
| SCHEMBL29557419 | 0.69 | CA12 (0.35) | KDM4EALDH1A1HSD17B10LMNA | |
| SCHEMBL27198408 | 0.67 | ALDH1A1 (0.57) | KDM4EALDH1A1HSD17B10 | |
| SCHEMBL30831886 | 0.67 | ALDH1A1 (0.57) | KDM4EALDH1A1HSD17B10 | |
| SCHEMBL3831246 | 0.65 | TTR (0.37) | — | |
| SCHEMBL11486192 | 0.65 | LMNA (0.30) | LMNA | |
| SCHEMBL4587818 | 0.64 | TPMT (0.41) | KDM4EALDH1A1HSD17B10LMNATPMT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103570580-B | Preparation method of high-purity iopromide | BEIJING JINGWEI XINKANG PHARMACEUTICAL TECHNOLOGY DEV CO LTD | 2015-04-01 | — | — | CN | disclosed |
| CN-103570580-A | Preparation method of high-purity iopromide | BEIJING JINGWEI XINKANG MEDICAL TECHNOLOGY DEV CO LTD | 2014-02-12 | — | — | CN | disclosed |